Biohit Oyj — Director's Dealing 2017

Mar 3, 2017

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:00 am local time (EET)

Person subject to the notification requirement
Name: Korpela, Semi
Position: Chief Executive Officer

---

Initial Notification
Reference number: 74370089ATTSNBXJVT29_20170302113238_1

---

Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29

---

Transaction details
Transaction date: 2017-03-01
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Acquisition

Instrument: Share
ISIN: FI0009005482

Volume: 1240
Unit price: 5,29000 Euro

Aggregated transactions
Volume: 1240
Volume weighted average price: 5.29000 Euro

Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com